Yoshihiko Tasaki

Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer

Yoshihiko Tasaki, Miho Suzuki, Keisuke Katsushima et al. · Cancer Research · 2021 · 30 citations · Full text

Medicine, Oncology, Pharmacology +16

Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter Analysis

Toshiki Etani, Taku Naiki, Yosuke Sugiyama et al. · Oncology · 2020 · 29 citations

Medicine, Oncology, Pharmacology +17

Eosinophil may be a predictor of immune‐related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study

Yoshihiko Tasaki, Yosuke Sugiyama, Shuzo Hamamoto et al. · Cancer Medicine · 2023 · 28 citations · Full text

Life Sciences, Immunology, Oncology +17

Elevated eosinophils proportion as predictor of immune‐related adverse events after ipilimumab and nivolumab treatment of advanced and metastatic renal cell carcinoma

Yoshihiko Tasaki, Shuzo Hamamoto, Yosuke Sugiyama et al. · International Journal of Urology · 2023 · 17 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy of tapentadol for first-line opioid-resistant neuropathic pain in Japan

Yosuke Sugiyama, Tomoya Kataoka, Yoshihiko Tasaki et al. · Japanese Journal of Clinical Oncology · 2018 · 13 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +17